Concepts of Risk in Nanomedicine Research
Version of Record online: 3 JAN 2013
© 2012 American Society of Law, Medicine & Ethics, Inc.
The Journal of Law, Medicine & Ethics
Special Issue: SYMPOSIUM 1: Nanodiagnostics and Nanotherapeutics: Building Research Ethics and Oversight
Volume 40, Issue 4, pages 809–822, Winter 2012
How to Cite
Hogle, L. F. (2012), Concepts of Risk in Nanomedicine Research. The Journal of Law, Medicine & Ethics, 40: 809–822. doi: 10.1111/j.1748-720X.2012.00709.x
- Issue online: 3 JAN 2013
- Version of Record online: 3 JAN 2013
Risk takes center stage in ethical debates over nanomedical technologies. Yet concepts of risk may hold different meanings, and they are embedded within particular political, economic, and social contexts. This article discusses framings of risk in debates over medical innovations such as nanomedicine, and draws attention to organizational and institutional forms of risk which are less visible in bioethical policy debates. While significant, possibly unique risks may exist in specific nano-based products, risk may also arise from the very processes and procedures that develop, test, and oversee any novel technology. This supports recommendations to coordinate efforts through an interagency Working Group and a Secretary-level Advisory Committee to provide flexibility and sensitivity to emerging issues of concern.